Poland· PL-100003478
Aksoderm
A medicinal product containing retinoli palmitas, registered in Poland by Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI".
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Retinoli palmitas
- Manufacturer
- Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990285228
- gtin05909990285211
- gtin05909990285235
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Retinoli palmitas in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAquasol A Parenteral 100,000units/2ml solution for injection vialsImported (United States)
- SpainAUXINA A MASIVA 50.000 UI CAPSULAS BLANDASChiesi España S.A.U.
- NorwayVitamin A carlsonCarlson Nutritional Supplements
- SwitzerlandVitamin A Blache, AugensalbeBausch & Lomb Swiss AG
- FranceVITAMINE A PROVEPHARM 100 000 U.I./2 ml, solution injectable (I.M.)PROVEPHARM
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Spain · Auxina A Masiva
- Portugal · A-Vite
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/014895fd-d420-4ef4-91b2-21f58062c43d GET /v1/drugs/014895fd-d420-4ef4-91b2-21f58062c43d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "400 j.m./g",
"packaging": "05909990285228 ¦ OTC ¦ Skasowane ¦ 563\n1 op. 20 g w tubie\n05909990285211 ¦ OTC ¦ Skasowane ¦ 14286\n1 op. 20 g w pudełku\n05909990285235 ¦ OTC ¦ 46757\n1 tuba 30 g",
"substance": "Retinoli palmitas 40000 j.m.",
"common_name": "Retinoli palmitas",
"pl_product_id": "100003478",
"pozwolenie_nr": "02852",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about retinoli palmitas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.